argenx SE | ARGX - Cost Of Sales

Stock Price
657.40
Daily Change
5.40 0.83%
Monthly
-7.43%
Yearly
10.08%
Q1 Forecast
704.56

argenx SE reported $149.69M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Qiagen NV USD 217.43M 29.65M Dec/2025
UCB EUR 901M 50M Dec/2024